These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 15975788
1. Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors. Sherrill RG, Furfine ES, Hazen RJ, Miller JF, Reynolds DJ, Sammond DM, Spaltenstein A, Wheelan P, Wright LL. Bioorg Med Chem Lett; 2005 Aug 01; 15(15):3560-4. PubMed ID: 15975788 [Abstract] [Full Text] [Related]
2. Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains. Miller JF, Furfine ES, Hanlon MH, Hazen RJ, Ray JA, Robinson L, Samano V, Spaltenstein A. Bioorg Med Chem Lett; 2004 Feb 23; 14(4):959-63. PubMed ID: 15013001 [Abstract] [Full Text] [Related]
3. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors. Ghosh AK, Swanson LM, Cho H, Leshchenko S, Hussain KA, Kay S, Walters DE, Koh Y, Mitsuya H. J Med Chem; 2005 May 19; 48(10):3576-85. PubMed ID: 15887965 [Abstract] [Full Text] [Related]
4. Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands. Ali A, Reddy GS, Cao H, Anjum SG, Nalam MN, Schiffer CA, Rana TM. J Med Chem; 2006 Dec 14; 49(25):7342-56. PubMed ID: 17149864 [Abstract] [Full Text] [Related]
5. Synthesis and antiviral activity of P1' arylsulfonamide azacyclic urea HIV protease inhibitors. Huang PP, Randolph JT, Klein LL, Vasavanonda S, Dekhtyar T, Stoll VS, Kempf DJ. Bioorg Med Chem Lett; 2004 Aug 02; 14(15):4075-8. PubMed ID: 15225729 [Abstract] [Full Text] [Related]
6. Novel P1 chain-extended HIV protease inhibitors possessing potent anti-HIV activity and remarkable inverse antiviral resistance profiles. Miller JF, Brieger M, Furfine ES, Hazen RJ, Kaldor I, Reynolds D, Sherrill RG, Spaltenstein A. Bioorg Med Chem Lett; 2005 Aug 01; 15(15):3496-500. PubMed ID: 15990305 [Abstract] [Full Text] [Related]
7. Oximinoarylsulfonamides as potent HIV protease inhibitors. Yeung CM, Klein LL, Flentge CA, Randolph JT, Zhao C, Sun M, Dekhtyar T, Stoll VS, Kempf DJ. Bioorg Med Chem Lett; 2005 May 02; 15(9):2275-8. PubMed ID: 15837308 [Abstract] [Full Text] [Related]
8. Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor. Sévigny G, Stranix B, Tian B, Dubois A, Sauvé G, Petropoulos C, Lie Y, Hellmann N, Conway B, Yelle J. Antiviral Res; 2006 Jun 02; 70(2):17-20. PubMed ID: 16473417 [Abstract] [Full Text] [Related]
10. Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors. Böttcher J, Blum A, Dörr S, Heine A, Diederich WE, Klebe G. ChemMedChem; 2008 Sep 02; 3(9):1337-44. PubMed ID: 18720485 [Abstract] [Full Text] [Related]
11. Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere. Beaulieu PL, Wernic D, Abraham A, Anderson PC, Bogri T, Bousquet Y, Croteau G, Guse I, Lamarre D, Liard F, Paris W, Thibeault D, Pav S, Tong L. J Med Chem; 1997 Jul 04; 40(14):2164-76. PubMed ID: 9216835 [Abstract] [Full Text] [Related]
12. Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors. Yan J, Huang N, Li S, Yang LM, Xing W, Zheng YT, Hu Y. Bioorg Med Chem Lett; 2012 Mar 01; 22(5):1976-9. PubMed ID: 22306123 [Abstract] [Full Text] [Related]
13. Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains. Tamamura H, Koh Y, Ueda S, Sasaki Y, Yamasaki T, Aoki M, Maeda K, Watai Y, Arikuni H, Otaka A, Mitsuya H, Fujii N. J Med Chem; 2003 Apr 24; 46(9):1764-8. PubMed ID: 12699395 [Abstract] [Full Text] [Related]